Quinazoline based 1,3,5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study
Arch Pharm | 2019
Pathak P, Naumovich V, Grishina M, Shukla PK, Verma A, Potemkin V